- Investing Ideas
- /
- Global Buy the Dip
Global Buy the Dip
UPDATED May 07, 2024
Companies which may present a buying opportunity after a dip in share price.
2,828 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ZVRA | US$5.18 | 13.0% | 16.8% | US$216.6m | US$19.00 | PS7.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | kr3.05 | -10.6% | -45.1% | kr74.0m | kr8.00 | PS3.2x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$9.37 | 11.5% | -38.6% | US$241.7m | US$25.90 | PS4.8x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
A036200 | ₩10,650.00 | -3.4% | 45.1% | ₩318.3b | ₩13,500.00 | PE17.5x | E38.6% | 0.8% | Semiconductors | ||
CAI | AU$0.13 | 0% | -29.7% | AU$95.2m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
301325 | CN¥61.41 | -0.3% | n/a | CN¥7.6b | CN¥83.82 | PE22.2x | E24.9% | n/a | Capital Goods | ||
HHR | AU$0.007 | 0% | -77.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
301358 | CN¥37.17 | 6.1% | -11.2% | CN¥28.1b | n/a | PE19.3x | E30.3% | 1.1% | Capital Goods | ||
ACI | ₹629.50 | -3.5% | 15.2% | ₹77.6b | ₹743.00 | PE19.5x | E29.0% | 0.3% | Materials | ||
CLBIO | kr10.05 | -4.7% | -44.0% | kr216.0m | kr29.00 | PS7x | E114.8% | n/a | Pharmaceuticals & Biotech | ||
SEAPT | kr4.56 | -2.1% | -64.5% | kr1.6b | kr11.57 | PB0.9x | E54.2% | n/a | Energy | ||
FXPO | UK£0.50 | -1.9% | -54.6% | UK£293.9m | UK£1.41 | PB0.3x | E116.3% | 0% | Materials | ||
DIGN | kr1.56 | -2.5% | -60.8% | kr109.6m | kr8.60 | PS1.3x | E139.0% | n/a | Healthcare | ||
SONM | US$0.54 | 3.2% | -42.2% | US$23.5m | US$2.00 | PB1.1x | E139.9% | n/a | Tech | ||
A101390 | ₩7,440.00 | -4.9% | -33.0% | ₩67.1b | n/a | PB2.9x | E100.8% | n/a | Tech | ||
300442 | CN¥29.68 | -5.5% | -4.7% | CN¥52.0b | CN¥36.36 | PE26.8x | E28.7% | 1.7% | Software | ||
300820 | CN¥46.87 | -6.6% | -34.5% | CN¥10.7b | CN¥70.67 | PE22.6x | E23.9% | 0.9% | Capital Goods | ||
KCB | KSh30.05 | 0.3% | 2.0% | KSh96.7b | KSh48.65 | PB0.4x | E26.0% | 0% | Banks | ||
CABP | UK£1.36 | 2.3% | n/a | UK£345.6m | UK£1.78 | PE15.1x | E34.6% | n/a | Diversified Financials | ||
OX2 | kr41.54 | 3.5% | -39.5% | kr11.3b | kr70.75 | PE12.8x | E29.9% | n/a | Capital Goods | ||
XBRANE | kr0.20 | -7.6% | -99.8% | kr305.9m | n/a | PS1.3x | E93.7% | n/a | Pharmaceuticals & Biotech | ||
FLNC | US$20.82 | 16.7% | 5.4% | US$3.7b | US$30.38 | PS1.2x | E65.2% | n/a | Capital Goods | ||
631 | HK$6.46 | 17.2% | -39.5% | HK$21.4b | HK$10.52 | PE9.9x | E21.2% | 2.9% | Capital Goods | ||
ACR | AU$0.064 | 1.6% | 33.3% | AU$18.0m | n/a | PS1.6x | E115.3% | 0% | Pharmaceuticals & Biotech |